Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens

International Journal of Antimicrobial Agents

Volumn 46, Issue 1, 2015, Pages 101-107

  Flynn, Padrig B ^a   Higginbotham, Sarah ^a   Alshraiedeh, Nid'a H ^a,b   Gorman, Sean P ^a   Graham, William G ^a   Gilmore, Brendan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Atmospheric pressure plasma; Biocide; Biofilm; ESKAPE pathogens; Non thermal plasma; Plasma medicine

Indexed keywords

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; ATMOSPHERIC PRESSURE NON THERMAL PLASMA; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIOPLANKTON; BIOFILM; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS FAECIUM; ERADICATION THERAPY; GROWTH INHIBITION; HEALTH HAZARD; HOSPITAL INFECTION; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; METABOLIC ACTIVITY ASSAY; NONHUMAN; PATHOPHYSIOLOGY; PLATE COUNT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; BACTERIAL COUNT; DEVICES; DISINFECTION; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MICROBIAL VIABILITY; PHARMACOLOGY; PHYSIOLOGY; PLASMA GAS; PROCEDURES;

ANTIINFECTIVE AGENT; PLASMA GAS;

ANTI-BACTERIAL AGENTS; BIOFILMS; COLONY COUNT, MICROBIAL; DISINFECTION; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL VIABILITY; PLASMA GASES;

EID: 84935004684     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.02.026     Document Type: Article

References (30)

1. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197:1079-81.
2. Kelly KN, Monson JRT. Hospital-acquired infections. Surgery 2012; 30:640-4.
3. O'Connor N., Cahill O, Daniels S., Galvin S, Humphreys H. Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections? J Hosp Infect 2014; 88:59-65.
4. Revdiwala S, Rajdev BM, Mulla S. Characterization of bacterial etiologic agents of biofilm formation in medical devices in critical care setup. Crit Care Res Pract 2012; 2012:945805.
5. Alkawareek MY, Algwari QT, Laverty G, Gorman S.P., Graham WG, O'Connell D, et al. Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure non-thermal plasma. PLoS ONE 2012; 7:e44289.
6. Römling U, Kjelleberg S, Normark S., Nyman L, Uhlin BE, Åkerlund B. Microbial biofilm formation: a need to act. J Intern Med 2014; 276:98-110.
7. Wolcott RD, Ehrlich GD. Biofilms and chronic infections. JAMA 2008; 299: 2682-4.
8. Howard SJ, Catchpole M, Watson J., Davies SC. Antibiotic resistance: global response needed. Lancet Infect Dis 2013; 13:1001-3.
9. Abreu AC, Tavares RR, Borges A, Mergulhão F, Simões M. Current and emergent strategies for disinfection of hospital environments. J Antimicrob Chemother 2013; 68:2718-32.
10. Montie TC, Kelly-Wintenberg K, Roth JR. An overview of research using the one atmosphere uniform glow discharge plasma (OAUGDP) for sterilization of surfaces and materials. IEEE Trans Plasma Sci 2000; 28:41-50.
11. Mai-Prochnow A, Murphy AB, McLean K.M., Kong MG, Ostrikov KK. Atmospheric pressure plasmas: infection control and bacterial responses. Int J Antimicrob Agents 2014; 43:508-17.
12. Alkawareek MY, Algwari QT, Gorman S.P., Graham WG, O'Connell D, Gilmore BF. Application of atmospheric pressure nonthermal plasma for the in vitro eradication of bacterial biofilms. FEMS Immunol Med Microbiol 2012; 65:381-4.
13. Kramer A, Lademann J, Bender C., Sckell A, Hartmann B, Münch S, et al. Suitability of tissue tolerable plasmas (TTP) for the management of chronic wounds. Clin Plasma Med 2013; 1:11-8.
14. Schlegel J, Köritzer J, Boxhammer V. Plasma in cancer treatment. Clin Plasma Med 2013; 1:2-7.
15. Alkawareek MY, Gorman SP, Graham W.G., Gilmore BF. Potential cellular targets and antibacterial efficacy of atmospheric pressure non-thermal plasma. Int J Antimicrob Agents 2014; 43:154-60.
16. Ermolaeva SA, Varfolomeev AF, Chernukha M.Y., Yurov DS, Vasiliev MM, Kaminskaya AA, et al. Bactericidal effects of non-thermal argon plasma in vitro, in biofilms and in the animal model of infected wounds. J Med Microbiol 2011; 60:75-83.
17. Albesa I, Becerra MC, Battán PC, Páez PL Oxidative stress involved in the antibacterial action of different antibiotics. Biochem Biophys Res Commun 2004; 317:605-9.
18. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001; 33:1387-92.
19. Cahill OJ, Claro T, O'Connor N, Cafolla AA, Stevens N.T., Daniels S., et al. Cold air plasma to decontaminate inanimate surfaces of the hospital environment. Appl Environ Microbiol 2014; 80:2004-10.
20. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538-82.
21. Otter JA, Yezli S, French GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 2011; 32:687-99.
22. Orsinger-Jacobsen SJ, Patel SS, Vellozzi E.M., Gialanella P., Nimrichter L, Miranda K, et al. Use of a stainless steel washer platform to study Acinetobacter baumannii adhesion and biofilm formation on abiotic surfaces. Microbiology 2013; 159:2594-604.
23. Mikkelsen H, McMullan R, Filloux A. The Pseudomonas aeruginosa reference strain PA14 displays increased virulence due to a mutation in ladS. PLoS ONE 2011; 6:e29113.
24. Joshi SG, Paff M, Friedman G., Fridman G, Fridman A, Brooks AD. Control of methicillin-resistant Staphylococcus aureus in planktonic form and biofilms: a biocidal efficacy study of nonthermal dielectric-barrier discharge plasma. Am J Infect Control 2010; 38:293-301.
25. Burts ML, Alexeff I, Meek E.T., McCullers JA. Use of atmospheric non-thermal plasma as a disinfectant for objects contaminated with methicillin-resistant Staphylococcus aureus. Am J Infect Control 2009; 37:729-33.
26. Laroussi M, Mendis D, Rosenberg M. Plasma interaction with microbes. NewJ Phys 2003; 5:41, 1-41.10.
27. Clauditz A, Resch A, Wieland K.P., Peschel A., Götz F. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun 2006; 74:4950-3.
28. Joshi SG, Cooper M, Yost A., Paff M, Ercan UK, Fridman G, et al. Nonthermal dielectric-barrier discharge plasma-induced inactivation involves oxidative DNA damage and membrane lipid peroxidation in Escherichia coli. Antimicrob Agents Chemother 2011; 55:1053-62.
29. Cooper M, Fridman G, Fridman A., Joshi SG. Biological responses of Bacillus stratosphericus to floating electrode-dielectric barrier discharge plasma treatment. J Appl Microbiol 2010; 109:2039-48.
30. Traylor MJ, Pavlovich MJ, Karim S, Hait P., Sakiyama Y, Clark DS, et al. Longterm antibacterial efficacy of air plasma-activated water. J Phys D Appl Phys 2011; 44:472001.